Vitamin E may help Alzheimer's patients live longer

Apr 16, 2008

People with Alzheimer's disease who take vitamin E appear to live longer than those who don't take vitamin E, according to research that will be presented at the American Academy of Neurology 60th Anniversary Annual Meeting in Chicago, April 12–19, 2008.

For the study, researchers followed 847 people with Alzheimer's disease for an average of five years. About two-thirds of the group took 1,000 international units of vitamin E twice a day along with an Alzheimer’s drug (a cholinesterase inhibitor). Less than 10 percent of the group took vitamin E alone and approximately 15 percent did not take vitamin E.

The study found people who took vitamin E, with or without a cholinesterase inhibitor, were 26 percent less likely to die than people who didn't take vitamin E.

"Vitamin E has previously been shown to delay the progression of moderately severe Alzheimer’s disease. Now, we've been able to show that vitamin E appears to increase the survival time of Alzheimer's patients as well," said study author Valory Pavlik, PhD, with Baylor College of Medicine’s Alzheimer’s Disease and Memory Disorders Center in Houston, TX, and member of the American Academy of Neurology. “This is particularly important because recent studies in heart disease patients have questioned whether vitamin E is beneficial for survival.”

In addition, the study found vitamin E plus a cholinesterase inhibitor may be more beneficial than taking either agent alone. "Our findings show that people who took a cholinesterase inhibitor without vitamin E did not have a survival benefit,” said Pavlik. “More research needs to be done to determine why this may be the case.”

In addition to vitamin E supplements, some vegetables oils, nuts, and green leafy vegetables are main food sources of vitamin E. Some fortified cereals in the United States also contain vitamin E. “The daily amount of vitamin E taken by patients in this study was much higher than what is currently recommended for the general population,” said Pavlik.

Source: American Academy of Neurology

Explore further: Nocturnal GERD tied to non-infectious rhinitis

add to favorites email to friend print save as pdf

Related Stories

Vitamin B12 may reduce risk of Alzheimer's disease

Oct 18, 2010

A new study shows that vitamin B12 may protect against Alzheimer's disease, adding more evidence to the scientific debate about whether the vitamin is effective in reducing the risk of memory loss. The research will be published ...

Alzheimer's advances show need for better drugs

Jul 12, 2010

Scientists are reporting advances in detecting and predicting Alzheimer's disease at a conference in Honolulu this week, plus more proof that getting enough exercise and vitamin D may lower your risk.

High blood levels of vitamin E reduces risk of Alzheimer's

Jul 05, 2010

High levels of several vitamin E components in the blood are associated with a decreased risk for Alzheimer's disease (AD) in advanced age, suggesting that vitamin E may help prevent cognitive deterioration in elderly people. ...

Recommended for you

Nocturnal GERD tied to non-infectious rhinitis

1 hour ago

(HealthDay)—Nocturnal gastroesophageal reflux disease (GERD) appears to be a risk factor for non-infectious rhinitis (NIR), according to a study published online March 24 in Allergy.

UK nurse cured of Ebola after receiving new treatment

4 hours ago

A British army reservist who contracted Ebola while working as a volunteer nurse in Sierra Leone has fully recovered after becoming the first patient in the world to receive an experimental new treatment.

COPD takes big toll on employment, mobility in US

4 hours ago

(HealthDay)—The respiratory illness known as COPD takes a toll on mobility and employment, with a new report finding that nearly one-quarter of Americans with the condition are unable to work.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.